Public market insider selling at ImmunoPrecise Antibodies (V:IPA)

Miko Malberg, a 10% Holder, disposed of 168,000 Common Shares on an indirect ownership basis for registered holder Kokkuhoideur OU,680,000 Common Shares on an indirect ownership basis for registered holder Serenga OU and 168,000 Common Shares on an indirect ownership basis for registered holder Topanga OU at prices ranging from $1.854 to $1.895 between September 9th and 11th, 2020. This represents a $1,906,080 divestment of the company's shares and an account share holdings change of -17.2%.

ImmunoPrecise Antibodies is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Immunoprecise Antibodies Ltd, formerly Tanqueray Exploration Ltd, is a Canada-based supplier of custom hybridoma development services. The Company's geographical segments include United States of America and Canada. It offers products, such as antibodies and hybridoma licensing. It offers various services, such as ImmunoProtect, Monoclonal Development, Polyclonal Development, Antibody Protection, Peptide Production and Cryopreservation Services. Its antibody products include IPA006A, IPA006B and IPA006F, which it offers to the research and industrial community. Its hybridoma licensing products include Anti-Human P38a (MAPKinase) Monoclonal Antibody Hybridoma Cell Line and Anti-Acetylated Lysine Monoclonal Antibody Hybridoma Cell Line. It offers cryopreservation storage service for the secure storage of users' valuable biological materials, including hybridoma clones, plasmid constructs and cell lines. It also offers both peptide synthesis and protein carrier conjugation services.